herp
simplex
viru
virion
consist
inner
core
linear
doublestrand
dna
enclos
capsid
outer
envelop
contain
variou
glycoprotein
cover
tegument
protein
exterior
viral
capsid
lytic
infect
cycl
begin
adsorpt
virion
first
attach
fuse
host
cell
attach
penetr
take
place
viral
glycoprotein
bind
suitabl
receptor
plasma
membran
host
cell
presenc
receptor
determin
tropism
place
limit
type
cell
capabl
attach
thu
infect
green
oolong
black
tea
produc
plant
camellia
sinensi
main
type
flavanol
green
tea
extract
catechin
bte
theaflavin
dimer
differ
catechin
includ
theaflavin
sinc
green
tea
ferment
contain
rel
high
amount
catechin
compar
black
tea
ferment
caus
catechin
polymer
produc
theaflavin
thearubigen
found
black
tea
absent
green
tea
benefit
tea
often
attribut
antioxid
properti
turn
ascrib
catechin
sinc
green
tea
extract
found
antioxid
activ
black
tea
extract
howev
recent
studi
shown
concentr
theaflavin
extract
made
black
tea
effect
catechin
believ
high
number
hydroxyl
oh
group
theaflavin
shown
protect
cell
oxid
damag
respons
antioxid
properti
addit
found
theaflavin
capabl
inhibit
certain
type
cancer
well
inhibit
virus
includ
bovin
rotaviru
bovin
coronaviru
three
differ
subtyp
influenza
strain
shown
inhibit
compound
green
tea
extract
varieti
polyphenol
compound
purpos
studi
determin
black
tea
extract
concentr
amount
theaflavin
bte
could
also
inhibit
sinc
theaflavin
bte
compos
dimer
structur
form
catechin
monom
found
green
tea
found
inhibit
reason
infer
theaflavin
bte
may
also
produc
similar
result
base
structur
similar
despit
fact
theaflavin
molecul
larger
catechin
larger
polyphenol
compound
tannin
shown
inhibit
virus
indic
size
molecul
may
necessarili
factor
requir
viral
inhibit
rather
larg
amount
hydroxyl
group
polyphenol
compound
seem
one
common
structur
compon
among
variou
natur
viral
inhibitor
thu
bte
high
concentr
theaflavin
may
effect
inhibitor
human
epitheli
cell
american
type
cultur
collect
atcc
manassa
va
usa
cultur
confluent
ham
nutrient
media
kaighn
modif
mm
lglutamin
supplement
contain
fetal
bovin
serum
fb
biowest
miami
fl
usa
gentamicin
vero
cell
atcc
manassa
va
cultur
confluent
dulbecco
modifi
eagl
medium
dmem
fb
gentamicin
recombin
strain
contain
sequenc
green
fluoresc
protein
gfp
fuse
tegument
protein
use
experi
atcc
manassa
va
usa
passag
viru
perform
flask
cell
allow
reach
complet
cytopath
effect
cpe
media
collect
centrifug
supernat
contain
viru
kept
cryogen
vial
black
tea
extract
theaflavin
bte
mg
sigmaaldrich
saint
loui
mo
usa
dissolv
ml
fbsmedia
produc
stock
concentr
mm
bte
solut
tenfold
dilut
mm
nm
stock
store
microcentrifug
tube
cell
morpholog
assess
use
accuscop
microscop
compar
treat
untreat
sampl
vero
cell
plate
plate
grown
h
differ
concentr
bte
mm
nm
ad
well
h
bte
remov
aspir
cell
wash
pb
fresh
media
ad
well
cell
examin
morpholog
chang
addit
hour
incub
vero
cell
plate
plate
hour
differ
concentr
bte
ad
well
one
hour
bte
aspir
cell
wash
pb
cell
includ
control
group
incub
media
hour
cell
stain
trypan
blue
count
use
hemocytomet
vero
cell
suspens
transfer
separ
well
plate
well
contain
sampl
cell
prolifer
reagent
roch
diagnost
indianapoli
usa
ad
plate
gentli
rock
place
incub
minut
absorb
level
well
measur
nm
micropl
reader
bte
solut
mix
microcentrifug
tube
incub
hour
mixtur
ad
separ
well
plate
contain
vero
cell
media
aspir
plate
incub
hour
rock
everi
minut
hour
unabsorb
viru
aspir
ml
fbsmedia
ad
well
vero
cell
incub
hour
media
well
harvest
use
infect
fresh
monolay
vero
cell
confluent
plate
incub
hour
monitor
cytopath
effect
viru
titer
determin
plaqu
assay
vero
cell
plate
plate
ml
cell
suspens
ad
well
incub
confluent
media
aspir
cell
well
treat
one
concentr
bte
solut
plate
rock
kept
incub
minut
unabsorb
solut
aspir
viru
ad
well
cell
incub
hour
rock
everi
minut
hour
unabsorb
viru
aspir
ml
fbsmedia
ad
well
plate
incub
hour
media
well
harvest
store
obtain
media
virion
vero
cell
infect
viru
particl
treat
bte
solut
undilut
mix
bte
solut
microcentrifug
tube
concentr
bte
solut
mixtur
remain
room
temperatur
minut
mixtur
ad
separ
well
plate
contain
vero
cell
respect
media
aspir
plate
incub
hour
rock
everi
minut
hour
unabsorb
viru
aspir
ml
fbsmedia
ad
well
cell
incub
hour
media
well
harvest
store
tenfold
serial
dilut
celltreat
virustr
extract
prepar
prior
infect
confluent
vero
cell
monolay
infect
differ
dilut
allow
adsorb
hour
unabsorb
virus
aspir
plate
overlaid
nutrient
mediumcontain
agar
incub
day
plaqu
visual
stain
cell
crystal
violet
count
within
hour
plaqu
assay
carri
triplic
experiment
well
plate
contain
confluent
monolay
vero
cell
infect
viru
suspens
produc
plaqu
per
well
h
incub
unabsorb
virion
aspir
bte
solut
mm
mm
respect
ad
appropri
well
follow
nutrient
mediumcontain
agar
plate
incub
day
plaqu
count
describ
equal
volum
bte
solut
viru
suspens
contain
viru
yield
plaqu
per
well
place
microcentrifug
tube
mixtur
incub
h
sampl
place
monolay
vero
cell
plate
viru
allow
adsorb
presenc
extract
unabsorb
solut
aspir
nutrient
mediumcontain
agar
ad
well
plate
incub
day
adsorpt
effici
assess
count
plaqu
describ
bte
solut
ad
well
plate
contain
monolay
vero
cell
plate
incub
h
extract
solut
remov
viru
suspens
contain
viru
yield
plaqu
per
well
ad
well
plate
incub
h
allow
attach
monolay
rins
time
cold
pb
unabsorb
solut
aspir
nutrient
mediumcontain
agar
ad
well
plate
incub
day
plaqu
count
describ
viru
suspens
prepar
ice
produc
plaqu
per
well
monolay
vero
cell
plate
viru
suspens
place
cell
plate
incub
h
allow
attach
bte
solut
ad
well
room
temperatur
plate
incub
minut
allow
penetr
unattach
virion
wash
pb
ph
unabsorb
solut
aspir
nutrient
mediumcontain
agar
ad
well
plate
incub
day
plaqu
count
describ
visual
effect
bte
solut
viral
propag
vero
cell
plate
plate
first
mix
bte
solut
microcentrifug
tube
mixtur
remain
room
temperatur
minut
mixtur
ad
separ
well
plate
contain
confluent
cell
cell
incub
hour
rock
everi
minut
unabsorb
solut
aspir
cell
ml
fbsmedia
ad
well
plate
incub
cell
observ
fluoresc
microscop
magnif
everi
hour
postinfect
hour
dna
extract
infect
vero
cell
contain
either
fbsmedia
fbsmedia
respect
equal
volum
viru
treat
microcentrifug
tube
either
mm
bte
solut
fbsmedia
cell
one
follow
lysat
mm
concentr
vero
cell
cell
incub
hour
dna
five
group
cell
extract
qiagen
blood
tissu
kit
qiagen
scienc
germantown
md
usa
follow
manufactur
protocol
quantifi
total
amount
dna
extract
dna
pcr
product
nanodrop
spectrophotomet
accompani
comput
softwar
nanodrop
technolog
incorpor
wilmington
de
usa
util
follow
manufactur
protocol
three
set
primer
design
prime
differ
region
genom
base
publish
sequenc
encod
glycoprotein
gfp
encod
gene
sequenc
melt
temperatur
tm
size
amplicon
forward
revers
primer
list
tabl
dna
ng
extract
treat
infect
vero
cell
ad
pcr
reaction
standard
pcr
amplif
perform
reaction
initi
denatur
minut
follow
cycl
denatur
second
anneal
minut
extens
second
follow
final
extens
period
minut
confirm
correct
amplicon
size
determin
agaros
gel
electrophoresi
ethidium
bromid
stain
vero
cell
expos
tenfold
dilut
bte
mm
nm
signific
chang
morpholog
determin
phase
contrast
microscopi
observ
test
concentr
bte
cell
data
shown
howev
slight
chang
morpholog
observ
vero
cell
highest
concentr
data
shown
vero
cell
appear
toler
exposur
bte
mm
data
shown
cell
viabil
quantit
determin
use
trypan
blue
hemocytomet
direct
cell
count
detect
effect
bte
cell
figur
viabil
btetreat
cell
similar
posit
control
group
treat
fbsmedia
concentr
bte
increas
percentag
cell
death
increas
test
concentr
bte
mm
nm
appear
cytotox
cell
one
unexplain
deviat
group
mm
bte
significantli
higher
percentag
live
cell
compar
group
result
compar
vero
cell
data
shown
bte
concentr
therefor
use
inhibit
studi
confirm
find
establish
trypan
blue
assay
assay
use
reagent
conduct
assay
live
cell
reduc
light
red
formazan
dark
red
thu
higher
absorb
level
indic
darker
color
correl
number
live
cell
overal
find
assay
cell
figur
vero
cell
data
shown
parallel
found
trypan
blue
assay
visual
observ
cytopath
effect
cpe
vero
cell
determin
bte
could
inhibit
either
reduc
prevent
observ
cpe
treat
untreat
cell
infect
observ
magnif
use
phase
contrast
microscopi
clear
differ
group
seen
hour
hour
postinfect
data
shown
plaqu
assay
conduct
test
effect
bte
titer
determin
plaqu
assay
viral
extract
vero
cell
report
tabl
treatment
bte
result
significantli
reduc
viral
titer
compar
untreat
group
treatment
virion
variou
concentr
bte
one
hour
result
significantli
reduc
viral
titer
compar
untreat
viru
confirm
find
phase
contrast
microcopi
plaqu
assay
fluoresc
microscopi
employ
visual
examin
progeni
virion
cell
expos
treat
mm
bte
sampl
hour
postinfect
pronounc
fluoresc
cell
infect
untreat
figur
yet
viral
fluoresc
detect
either
control
cell
treat
fbsmedia
data
shown
cell
inocul
treat
bte
figur
hour
postinfect
still
signific
amount
fluoresc
cell
infect
untreat
figur
small
amount
fluoresc
cell
inocul
treat
bte
figur
vero
cell
infect
untreat
signific
amount
fluoresc
hour
postinfect
vero
cell
infect
increasingli
higher
concentr
bte
show
decreas
level
fluoresc
figur
pcr
amplif
btetreat
infect
vero
cell
indic
replic
viral
gene
glycoprotein
gfp
reduc
follow
treatment
higher
concentr
bte
determin
treatment
bte
interf
product
viral
genom
pcr
use
compar
rel
level
total
dna
produc
infect
btetreat
untreat
approxim
reduct
concentr
dna
cell
follow
treatment
mm
bte
tabl
gel
electrophoresi
pcr
product
dna
extract
infect
cell
result
visibl
band
gel
correspond
viral
gene
glycoprotein
gd
gfp
appar
untreat
treat
mm
bte
howev
former
higher
intens
latter
figur
sequencespecif
primer
also
use
amplifi
viral
dna
extract
infect
vero
cell
encod
viral
gfp
hour
postinfect
untreat
treat
vari
concentr
bte
figur
intens
viral
dna
product
obtain
infect
untreat
column
greater
treat
mm
bte
column
subsequ
experi
focus
higher
concentr
bte
affect
infect
determin
treatment
bte
interf
viral
adsorpt
vero
cell
either
part
whole
four
assay
perform
compar
untreat
sampl
infect
plaqu
reduct
assay
slight
reduct
plaqu
observ
bte
treat
group
figur
possibl
due
inhibitori
effect
bte
previous
mention
viru
adsorpt
assay
figur
show
reduc
number
plaqu
bte
treat
sampl
indic
part
adsorpt
affect
two
addit
assay
perform
assess
aspect
viral
adsorpt
affect
viru
attach
assay
display
signific
reduct
plaqu
form
bte
treat
group
figur
penetr
assay
show
similar
reduct
plaqu
format
bte
treat
group
figur
lead
consum
beverag
worldwid
water
tea
centuri
tea
recogn
medicin
use
herbal
treatment
multipl
ailment
rang
simpl
indigest
atherosclerosi
theaflavin
polyphenol
found
mainli
black
tea
natur
antioxid
viral
inhibitor
black
tea
extract
may
use
futur
pharmaceut
develop
one
concern
human
health
infect
caus
herpesviru
estim
affect
anywher
world
popul
infect
individu
subject
recurr
outbreak
often
result
infecti
lesion
ulcer
skin
treatment
drug
acyclovir
use
today
reli
presenc
viral
protein
thymidin
kinas
inhibit
viral
replic
mutant
viral
strain
lack
enzym
still
infecti
respond
avail
medic
addit
current
treatment
detriment
side
effect
often
requir
frequent
dose
expens
thu
altern
lower
cost
treatment
infect
necessari
allevi
symptom
infect
individu
black
tea
extract
previous
found
block
product
free
radic
inhibit
growth
cancer
cell
well
exhibit
cytotox
effect
immort
cell
purpos
studi
assess
antivir
qualiti
black
tea
extract
determin
lowest
inhibitori
concentr
hypothesi
stem
find
black
tea
compound
shown
inhibit
virus
addit
green
tea
catechin
egcg
alreadi
shown
inhibit
suggest
compound
bind
glycoprotein
envelop
viru
therebi
prevent
viral
entri
host
cell
sinc
black
tea
theaflavin
mere
polym
green
tea
catechin
possibl
former
may
also
inhibit
though
differ
mechan
addit
flavanol
black
tea
may
stabl
green
tea
although
stabil
green
tea
catechin
ph
depend
egcg
egc
less
stabl
ec
ecg
regardless
ph
theaflavin
howev
report
stabl
ph
egc
egcg
increas
stabil
theaflavin
neutral
ph
could
make
black
tea
compound
feasibl
option
design
antivir
therapeut
agent
egcg
inhibit
measur
visual
observ
util
phase
contrast
fluoresc
microscopi
well
quantit
determin
viral
titer
plaqu
assay
method
viral
dna
concentr
sampl
extract
infect
cell
phase
contrast
microscopi
plaqu
assay
demonstr
bte
significantli
inhibit
infecti
cycl
consist
find
previou
studi
experi
demonstr
noncytotox
concentr
bte
effect
inhibit
infecti
cycl
cultur
cell
similarli
treatment
bte
one
hour
significantli
reduc
viral
titer
inactiv
virion
fluoresc
microscopi
reveal
treatment
virion
higher
concentr
bte
interf
infecti
cycl
viru
cultur
vero
cell
specif
pcr
gel
electrophoresi
indic
higher
concentr
viral
dna
produc
untreat
infect
compar
lower
viral
dna
concentr
btetreat
also
direct
relationship
increas
bte
concentr
reduc
intens
sampl
contain
viral
gfp
suggest
signific
reduct
viral
genom
replic
btetreat
infect
vero
cell
cultur
addit
plaqu
assay
indic
attach
penetr
process
adsorpt
cell
vero
cell
inhibit
bte
concentr
mm
experiment
result
taken
whole
indic
bte
noncytotox
concentr
inhibit
viral
propag
limit
viral
process
replic
adsorpt
report
treatment
h
complet
inactiv
viru
effect
treatment
bte
h
dose
depend
result
indic
viru
inactiv
follow
h
treatment
bte
therefor
action
alon
may
explain
efficaci
bte
treatment
mm
bte
caus
reduct
amount
genom
synthes
h
infect
concentr
lower
viral
count
bte
report
lack
cytotox
effect
cultur
cell
consist
find
therefor
bte
concentr
mm
use
treat
cell
infect
studi
inhibitori
effect
data
present
indic
bte
safe
appli
cell
concentr
test
lower
cost
bte
compar
pure
theaflavin
make
attract
consider
safe
effect
antivir
agent
bte
consist
primarili
theaflavin
concentr
higher
reduc
block
product
infecti
virion
cultur
vero
cell
thu
inhibit
infect
viru
interf
attach
penetr
well
dna
replic
particl
find
indic
bte
enrich
theaflavin
potenti
develop
safe
therapeut
antivir
agent
prevent
spread
author
declar
compet
interest
sda
ac
design
studi
sda
supervis
ac
sdr
dt
laboratori
sda
ac
draft
manuscript
ac
conduct
experi
use
cell
sda
sdr
dt
conduct
experi
use
vero
cell
author
read
approv
final
manuscript
prepubl
histori
paper
access
http
